These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 4200296)
1. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase. Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296 [No Abstract] [Full Text] [Related]
2. Hydroxyurea, leucopheresis, and splenectomy in chronic myeloid leukaemia at the problastic phase. Schwarzenberg L; Mathé G; Pouillart P; Weiner R; Locour J; Genin J; Schneider M; De Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C Br Med J; 1973 Mar; 1(5855):700-3. PubMed ID: 4512003 [TBL] [Abstract][Full Text] [Related]
3. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia]. Kiss A; Jakó J; Rák K Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539 [No Abstract] [Full Text] [Related]
4. [Splenectomy in myelocytic leukemia]. Petukhov VI Ter Arkh; 1980; 52(10):135-40. PubMed ID: 7003790 [No Abstract] [Full Text] [Related]
5. Proceedings: The chronic leukemias: current therapeutic concepts. Canellos GP; De Vita VT; Schein P; Chabner B; Young RC Proc Natl Cancer Conf; 1972; 7():351-7. PubMed ID: 4520052 [No Abstract] [Full Text] [Related]
6. [Effect of hydroxyurea treatment on free nucleotides in leukemic leukocytes]. Maj S; Zdebska E Acta Haematol Pol; 1975; 6(3):211-6. PubMed ID: 1057841 [TBL] [Abstract][Full Text] [Related]
7. Splenic irradiation following chemotherapy in chronic myelogenous leukemia. Wilson JF; Johnson RE Radiology; 1971 Dec; 101(3):657-61. PubMed ID: 5288778 [No Abstract] [Full Text] [Related]
8. A clinical trial of early splenectomy, hydroxyurea, and cyclic arabinosyl cytosine, vincristine, and prednisone in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Ser Haematol; 1975; 8(4):121-42. PubMed ID: 798282 [No Abstract] [Full Text] [Related]
9. Current concepts in chronic myelogenous leukemia. Stryckmans PA Semin Hematol; 1974 Apr; 11(2):101-27. PubMed ID: 4595812 [No Abstract] [Full Text] [Related]
10. The treatment of chronic granulocytic leukaemia. Canellos GP Clin Haematol; 1977 Feb; 6(1):113-28. PubMed ID: 334404 [No Abstract] [Full Text] [Related]
11. Daunorubicin in the therapy of acute granulocytic leukemia. Weil M; Glidewell OJ; Jacquillat C; Levy R; Serpick AA; Wiernik PH; Cuttner J; Hoogstraten B; Wasserman L; Ellison RR; Gailani S; Brunner K; Silver RT; Rege VB; Cooper MR; Lowenstein L; Nissen NI; Haurani F; Blom J; Boiron M; Bernard J; Holland JF Cancer Res; 1973 May; 33(5):921-8. PubMed ID: 4512953 [No Abstract] [Full Text] [Related]
18. A simultaneous study of bone marrow, spleen, and liver in chronic myeloid leukemia: evidence for differences in cell composition and karyotypes. Baccarani M; Zaccaria A; Santucci AM; Bagnara GP; Ricci P; Gobbi M; Ruggero D; Brunelli MA; Tura S Ser Haematol; 1975; 8(4):81-112. PubMed ID: 1071286 [No Abstract] [Full Text] [Related]
19. Clinical trial of hydroxyurea in chronic myelocytic leukemia. Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231 [No Abstract] [Full Text] [Related]